The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian populationMICROBIOLOGY SPECTRUMIF3.82023-12-124OAAI
The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variantJOURNAL OF MEDICAL VIROLOGYIF4.62023-01-173OA
Study of Viral Photoinactivation by UV-C Light and Photosensitizer Using a Pseudotyped ModelPHARMACEUTICSIF5.52022-03-2112OAAI
Photoinduced Photosensitizer-Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIVACS OMEGAIF4.32021-06-0815OAAI
New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-XSCIENTIFIC REPORTSIF3.92019-07-104OAAI
Intravenous Grafts of Human Amniotic Fluid-Derived Stem Cells Reduce Behavioral Deficits in Experimental Ischemic StrokeCELL TRANSPLANTATIONIF3.22019-06-0412OAAI
Tropism of mesenchymal stem cell toward CD133+ stem cell of glioblastoma in vitro and promote tumor proliferation in vivoSTEM CELL RESEARCH & THERAPYIF7.32018-11-0967OAAI
Calcium oxalate crystals and oxalate induce an epithelial-to-mesenchymal transition in the proximal tubular epithelial cells: Contribution to oxalate kidney injurySCIENTIFIC REPORTSIF3.92017-04-0756OAAI